2016
DOI: 10.4269/ajtmh.15-0690
|View full text |Cite
|
Sign up to set email alerts
|

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae

Abstract: Abstract. Treatment of mycobacterial diseases such as tuberculosis (TB) entails long and intense antimicrobial therapy. TB patients are at risk of coinfection with other multidrug-resistant bacteria, such as those from Enterobacteriaceae family, because of antimicrobial selection pressure and nosocomial transmission during prolonged hospital admission. Here, we report on two patients treated for multidrug-resistant TB, who developed severe sepsis due to an extended spectrum β-lactamase producing organism. Diag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 9 publications
0
4
0
1
Order By: Relevance
“…Although the abundance of these ARGs approaches pretreatment baseline by treatment cessation, the AMR expansion is persistent for at least the first 6 months of MDR TB treatment. Although there are scattered case reports of resistant infections in patients with MDR TB (86,87), our data suggest that MDR TB treatment might be a risk factor for antimicrobial-resistant Gram-negative infection. Such associations should be sought in future studies, both in individuals and in communities with high rates of MDR TB (88).…”
Section: Discussionmentioning
confidence: 66%
“…Although the abundance of these ARGs approaches pretreatment baseline by treatment cessation, the AMR expansion is persistent for at least the first 6 months of MDR TB treatment. Although there are scattered case reports of resistant infections in patients with MDR TB (86,87), our data suggest that MDR TB treatment might be a risk factor for antimicrobial-resistant Gram-negative infection. Such associations should be sought in future studies, both in individuals and in communities with high rates of MDR TB (88).…”
Section: Discussionmentioning
confidence: 66%
“…11 We previously raised special attention for MDRO resistance among patients with TB, leading to complications during TB treatment like bacteraemia and sepsis. 12 This patient illustrates the rationale behind screening for MDRO. The detection of carriage of CP microorganisms resulted in targeted prophylaxis during the surgical intervention and would have resulted in an adapted choice of empirical antimicrobial therapy in the case of infection.…”
Section: Discussionmentioning
confidence: 92%
“…This is an encouraging finding, as the occurrence of both in bacteria can yield both untreatable and virulent species. Co‐occurence of virulence and/or pathogenic factors is often problematic, as demonstrated with the recent COVID‐19 pandemic, with tuberculosis, and with other difficult‐to‐treat infections 87–89 . Bacteria develop resistance in response to exposure to antibiotics, while they develop virulence genes to survive in the host.…”
Section: Discussionmentioning
confidence: 99%
“…Co-occurence of virulence and/or pathogenic factors is often problematic, as demonstrated with the recent COVID-19 pandemic, with tuberculosis, and with other difficult-to-treat infections. [87][88][89] Bacteria develop resistance in response to exposure to antibiotics, while they develop virulence genes to survive in the host. Whereas resistance genes are mostly transmitted horizontally through plasmids or other mobile genetic elements, virulence genes are mainly transmitted vertically/clonally.…”
Section: F I G U R Ementioning
confidence: 99%